Mirum Pharmaceuticals
MIRM
96.13
+0.62
+0.65%
Mirum Pharmaceuticals
US · MIRM
#2051 by market cap
Listed 2019
96.13
+0.62
+0.65%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
RBC Capital Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $155Market Newswire · 2026/10/8
-
Rating change
TD Cowen Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $145Market Newswire · 2026/10/21
-
H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $202Market Newswire · 2026/11/11
-
Rating change
H.C. Wainwright Initiates Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Announces Target Price $195Market Newswire · 2026/10/22
-
Rating change
Leerink Partners Initiates Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Announces Target Price $140Market Newswire · 2026/11/5
-
Citi Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $194Market Newswire · 2026/11/11
-
Rating change
Baird Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $130Market Newswire · 2026/9/30
-
Rating change
Stifel Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $156Market Newswire · 2026/10/15
-
Citi Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $194Market Newswire · 2026/11/11
-
Rating change
H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $195Market Newswire · 2026/10/8
-
Rating change
Stifel Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $156Market Newswire · 2026/10/15
-
Rating change
Citizens JMP Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $167Market Newswire · 2026/11/4
-
Rating change
Evercore Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $146Market Newswire · 2026/10/13
-
Rating change
Citi Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $184Market Newswire · 2026/10/13
-
Rating change
Morgan Stanley Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $152Market Newswire · 2026/10/13
-
Rating change
H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $200Market Newswire · 2026/10/27
-
Morgan Stanley Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $152Market Newswire · 2026/11/5
-
Rating change
Citi Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $160Market Newswire · 2026/9/30
-
J.P. Morgan Maintains Mirum Pharmaceuticals(MIRM.US) With Buy RatingMarket Newswire · 2026/11/10
-
Rating change
Citi Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $184Market Newswire · 2026/11/10
-
Rating change
Analysts Are Bullish on These Healthcare Stocks: Maze Therapeutics, Inc. (MAZE), Mirum Pharmaceuticals (MIRM)TipRanks · 2026/9/10
-
Rating change
Citi Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $145Market Newswire · 2026/9/10
-
Morgan Stanley Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $152Market Newswire · 2026/10/13
-
Rating change
A Quick Look at Today's Ratings for Mirum Pharmaceuticals(MIRM.US), With a Forecast Between $130 to $195Market Newswire · 2026/9/29
-
Rating change
J.P. Morgan Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $118Market Newswire · 2026/8/11
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Mirum Pharmaceuticals discussion 0 comments